HY-126520-100mg
|
MedChemexpress LLC
|
N3-C2-NHS ester [CAS 850180-76-6]
|
|
Cancer-programmed cell death
|
|
HY-126520-25mg
|
MedChemexpress LLC
|
N3-C2-NHS ester [CAS 850180-76-6]
|
|
Cancer-programmed cell death
|
|
HY-126520-50mg
|
MedChemexpress LLC
|
N3-C2-NHS ester [CAS 850180-76-6]
|
|
Cancer-programmed cell death
|
|
HY-126521-100mg
|
MedChemexpress LLC
|
N3-C3-NHS ester [CAS 943858-70-6]
|
|
Cancer-programmed cell death
|
|
HY-126521-500mg
|
MedChemexpress LLC
|
N3-C3-NHS ester [CAS 943858-70-6]
|
|
Cancer-programmed cell death
|
|
HY-126522-100mg
|
MedChemexpress LLC
|
N3-C4-NHS ester [CAS 478801-48-8]
|
|
Cancer-programmed cell death
|
|
HY-126523-100mg
|
MedChemexpress LLC
|
N3-C5-NHS ester [CAS 866363-70-4]
|
|
Cancer-programmed cell death
|
|
HY-126523-500mg
|
MedChemexpress LLC
|
N3-C5-NHS ester [CAS 866363-70-4]
|
|
Cancer-programmed cell death
|
|
HY-126526-100mg
|
MedChemexpress LLC
|
N3-PEG2-C2-NHS ester [CAS 1312309-64-0]
|
|
Cancer-programmed cell death
|
|
HY-126526-250mg
|
MedChemexpress LLC
|
N3-PEG2-C2-NHS ester [CAS 1312309-64-0]
|
|
Cancer-programmed cell death
|
|
HY-126526-50mg
|
MedChemexpress LLC
|
N3-PEG2-C2-NHS ester [CAS 1312309-64-0]
|
|
Cancer-programmed cell death
|
|
HY-126528-1g
|
MedChemexpress LLC
|
N3-PEG3-C2-NHS ester [CAS 1245718-89-1]
|
|
Cancer-programmed cell death
|
|
HY-126528-100mg
|
MedChemexpress LLC
|
N3-PEG3-C2-NHS ester [CAS 1245718-89-1]
|
|
Cancer-programmed cell death
|
|
HY-126528-500mg
|
MedChemexpress LLC
|
N3-PEG3-C2-NHS ester [CAS 1245718-89-1]
|
|
Cancer-programmed cell death
|
|
HY-42489-100mg
|
MedChemexpress LLC
|
N3-PEG3-CH2CH2-Boc [CAS 252881-73-5]
|
|
Cancer-programmed cell death
|
|
HY-42489-250mg
|
MedChemexpress LLC
|
N3-PEG3-CH2CH2-Boc [CAS 252881-73-5]
|
|
Cancer-programmed cell death
|
|
HY-42489-50mg
|
MedChemexpress LLC
|
N3-PEG3-CH2CH2-Boc [CAS 252881-73-5]
|
|
Cancer-programmed cell death
|
|
HY-130109-100mg
|
MedChemexpress LLC
|
N3-PEG4-C2-NHS ester [CAS 944251-24-5]
|
|
Cancer-programmed cell death
|
|
HY-130109-25mg
|
MedChemexpress LLC
|
N3-PEG4-C2-NHS ester [CAS 944251-24-5]
|
|
Cancer-programmed cell death
|
|
HY-130109-50mg
|
MedChemexpress LLC
|
N3-PEG4-C2-NHS ester [CAS 944251-24-5]
|
|
Cancer-programmed cell death
|
|
HY-130108-100mg
|
MedChemexpress LLC
|
N3-PEG4-C2-Pfp ester [CAS 1353012-00-6]
|
|
Cancer-programmed cell death
|
|
HY-130108-25mg
|
MedChemexpress LLC
|
N3-PEG4-C2-Pfp ester [CAS 1353012-00-6]
|
|
Cancer-programmed cell death
|
|
HY-130108-50mg
|
MedChemexpress LLC
|
N3-PEG4-C2-Pfp ester [CAS 1353012-00-6]
|
|
Cancer-programmed cell death
|
|
HY-126524-100mg
|
MedChemexpress LLC
|
N3-Ph-NHS ester [CAS 53053-08-0]
|
|
Cancer-programmed cell death
|
|
HY-P99748-1mg
|
MedChemexpress LLC
|
Nadecnemab
|
|
|
|